Global advocacy, global leadership, global networks

The World Dementia Council helps change the lives of people with dementia by securing change internationally working with international governmental and non-governmental organisations. Through the collaborative strength of governments, industry, researchers and health and social care systems all working together we can transform the prospects for people affected by dementia in all its forms, so that the disease no longer negatively impacts on lives in the way it does today.
 

The World Dementia Council was established by the G8 (now G7) at the London Dementia Summit. The council has 24 members drawn from around the globe. At the London summit the G8 made historic commitments to improve the lives of people affected by dementia today and to speed up the development of disease modifying drugs so that the first treatment is available by 2025. The role of the World Dementia Council is to challenge and support international governmental organisation to realise and accede these ambition. Through monitoring progress, identifying what further international action is needed and building, expanding and nurturing global networks the World Dementia Council helps galvanise global efforts to beat dementia.

  • Achievements

    Since its formation in 2014, WDC has helped shape the UK-Government-led work to establish the Dementia Discovery Fund (DDF); facilitated and chaired meetings with international regulators from global jurisdictions for the first time, who continue to work collaboratively to improve dementia drug development; and acted as a catalyst for the World Health Organization’s (WHO) prioritisation of dementia, including through the creation of a Global Dementia Observatory and the Global Action Plan on the Public Health Response to Dementia.

  • History

    The World Dementia Council (WDC) was created in February 2014, following the G8 Dementia Summit in London in December 2013. The Summit resulted in a G8 Declaration, which set out an international response to dementia and a commitment to accelerate progress towards effective treatments and cures. Central to this was an ambition to identify a cure or a disease-modifying medicine for dementia by 2025 and a commitment to appoint a World Dementia Envoy to help achieve this goal.